The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.

Bruce W. Senile rheumatic gout. BMJ7 1988; 2: 811-13.

Hutchinson J. Diseases of the arteries No 1. On a peculiar form of thrombotic arteritis of the aged which is sometimes productive of gangrene. Archives of Surgery 1890;2: 323-9.

Bagratuni L. Anarthritic rheumatoid disease. Lancet 1956; 2: 694-7.

Bagratuni L. Prognosis in the anarthritic rheumatoid syndrome. BMJ 1963; 1: 513-8.

Fauchald R, Rygrold 0, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann IntMed 1972; 77: 845-52.

Myles A B. Polymyalgia rheumatica and giant cell arteritis. Rheum Rehab 1975; 14: 231-5.

Sorensen P S, Lorenzen I. Giant cell arteritis, temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1977;201: 207-13.

Bengtsson B E, Malmvall B A. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1981; 209: 337-45.

Behn A R, Perera T, Myles A B. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis 1983; 42: 374-8.

Ayoub W T, Franklin C M, Torretti D. Polymyalgia rheumatica. Duration of therapy and longterm outcome. Amer3 Med 1985; 79: 309-15.

Coomes E N, Ellis R M, Kay A G. A prospective study of 102 patients with polymyalgia rheumatica syndrome. Rheum Rehab 1976; 15: 270-5.

Huston K A, Hunder G G. Giant cell (cranial) arteritis: a clinical review. AmerHJ 1980; 100: 99-107.

Chuang T-Y, Hunder G G, Ilstrup D M, Kurland L T. Polymyalgic rheumatica. A 10 year epidemiological and clinical study. Ann Int Med 1982; 97: 672-80.

Whitfield A G W, Bateman M, Cooke W T. Temporal arteritis. BrJ Ophthalmol 1963; 47: 555-66.

Paulsen S, Iversen T 0. Rheumatic polymyalgia. Longterm treatment with steroids. Acta Rheum Scand 1977; 17: 165-8.

Huston K A, Hunder G G, Lie J T, Kennedy R H, Eweback L R. Temporal arteritis. A 25 year epidemiological clinical and pathologic study. Ann Int Med 1978; 88: 162-7.

Von Knorring J. Treatment and prognosis in polymyalgia rheumatica and giant cell arteritis. Acta Med Scand 1979; 205: 429-35.

Jones J G, Hazleman B L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981; 40: 1-5.

Knudsen L, Christenson G, Krohn L. Polymyalgia rheumatica syndrome. Scand J Rheumatol 1982; 11: 117-20.

Kyle V, Hazleman B L. Treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) I steroid regimens in the first 2 months. Ann Rheum Dis 1989; 48: 658-61.

Kyle V, Cawston T E, Hazleman B L. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989;48: 667-71.

Park J, Jones J, Hazleman B. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1981; 40: 493-5.